Identification of drug candidates against glioblastoma with machine learning and high-throughput screening of heterogeneous cellular models
{{output}}
Glioblastoma multiforme (GBM) is an aggressive primary brain tumour that presents significant treatment challenges due to its complex pathology and heterogeneity. The lack of validated molecular targets is a major obstacle for discovering new therapeutic candi... ...
